CNS Pharmaceuticals (CNSP) Stock Forecast, Price Target & Predictions
CNSP Stock Forecast
CNS Pharmaceuticals stock forecast is as follows: an average price target of $0.50 (represents a 304.53% upside from CNSP’s last price of $0.12) and
CNSP Price Target
CNS Pharmaceuticals Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | Jason McCarthy | Maxim Group | $0.50 | $0.15 | 225.52% | 304.53% |
The latest CNS Pharmaceuticals stock forecast, released on Sep 10, 2024 by Jason McCarthy from Maxim Group, set a price target of $0.50, which represents a 225.52% increase from the stock price at the time of the forecast ($0.15), and a 304.53% increase from CNSP last price ($0.12).
CNS Pharmaceuticals Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $0.50 | $0.50 |
| Last Closing Price | $0.12 | $0.12 | $0.12 |
| Upside/Downside | -100.00% | 304.53% | 304.53% |
In the current month, the average price target of CNS Pharmaceuticals stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CNS Pharmaceuticals's last price of $0.12. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
CNS Pharmaceuticals Financial Forecast
CNS Pharmaceuticals Revenue Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| Revenue | - | - | - |
| Avg Forecast | - | - | - |
| High Forecast | - | - | - |
| Low Forecast | - | - | - |
| # Analysts | - | - | - |
| Surprise % | - | - | - |
CNS Pharmaceuticals's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CNSP's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
CNS Pharmaceuticals EBITDA Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| EBITDA | - | - | - |
| Avg Forecast | - | - | - |
| High Forecast | - | - | - |
| Low Forecast | - | - | - |
| Surprise % | - | - | - |
undefined analysts predict CNSP's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than CNS Pharmaceuticals's previous annual EBITDA (undefined) of $NaN.
CNS Pharmaceuticals Net Income Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| Net Income | - | - | - |
| Avg Forecast | $-2.66M | $-2.22M | $505.68K |
| High Forecast | $-2.66M | $-2.22M | $505.68K |
| Low Forecast | $-2.66M | $-2.22M | $505.68K |
| Surprise % | - | - | - |
CNS Pharmaceuticals's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CNSP's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
CNS Pharmaceuticals SG&A Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| SG&A | - | - | - |
| Avg Forecast | - | - | - |
| High Forecast | - | - | - |
| Low Forecast | - | - | - |
| Surprise % | - | - | - |
CNS Pharmaceuticals's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CNSP last annual SG&A of $NaN (undefined).
CNS Pharmaceuticals EPS Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| EPS | - | - | - |
| Avg Forecast | $-0.12 | $-0.10 | $1.34 |
| High Forecast | $-0.12 | $-0.10 | $1.34 |
| Low Forecast | $-0.12 | $-0.10 | $1.34 |
| Surprise % | - | - | - |
According to undefined Wall Street analysts, CNS Pharmaceuticals's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CNSP previous annual EPS of $NaN (undefined).
CNS Pharmaceuticals Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals | $0.69 | $70.00 | 10044.93% | Buy |
| ELEV | Elevation Oncology | $0.58 | $9.00 | 1451.72% | Buy |
| CNSP | CNS Pharmaceuticals | $0.12 | $0.50 | 316.67% | - |
| IMMX | Immix Biopharma | $1.82 | $7.00 | 284.62% | Buy |
| VECT | VectivBio | $16.87 | $18.00 | 6.70% | Buy |
| EFTR | eFFECTOR Therapeutics | - | $5.50 | - | Buy |